Cargando…
Translational control of nociception via 4E-binding protein 1
Activation of the mechanistic/mammalian target of rapamycin (mTOR) kinase in models of acute and chronic pain is strongly implicated in mediating enhanced translation and hyperalgesia. However, the molecular mechanisms by which mTOR regulates nociception remain unclear. Here we show that deletion of...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695384/ https://www.ncbi.nlm.nih.gov/pubmed/26678009 http://dx.doi.org/10.7554/eLife.12002 |
_version_ | 1782407625371025408 |
---|---|
author | Khoutorsky, Arkady Bonin, Robert P Sorge, Robert E Gkogkas, Christos G Pawlowski, Sophie Anne Jafarnejad, Seyed Mehdi Pitcher, Mark H Alain, Tommy Perez-Sanchez, Jimena Salter, Eric W Martin, Loren Ribeiro-da-Silva, Alfredo De Koninck, Yves Cervero, Fernando Mogil, Jeffrey S Sonenberg, Nahum |
author_facet | Khoutorsky, Arkady Bonin, Robert P Sorge, Robert E Gkogkas, Christos G Pawlowski, Sophie Anne Jafarnejad, Seyed Mehdi Pitcher, Mark H Alain, Tommy Perez-Sanchez, Jimena Salter, Eric W Martin, Loren Ribeiro-da-Silva, Alfredo De Koninck, Yves Cervero, Fernando Mogil, Jeffrey S Sonenberg, Nahum |
author_sort | Khoutorsky, Arkady |
collection | PubMed |
description | Activation of the mechanistic/mammalian target of rapamycin (mTOR) kinase in models of acute and chronic pain is strongly implicated in mediating enhanced translation and hyperalgesia. However, the molecular mechanisms by which mTOR regulates nociception remain unclear. Here we show that deletion of the eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), a major mTOR downstream effector, which represses eIF4E activity and cap-dependent translation, leads to mechanical, but not thermal pain hypersensitivity. Mice lacking 4E-BP1 exhibit enhanced spinal cord expression of neuroligin 1, a cell-adhesion postsynaptic protein regulating excitatory synapse function, and show increased excitatory synaptic input into spinal neurons, and a lowered threshold for induction of synaptic potentiation. Pharmacological inhibition of eIF4E or genetic reduction of neuroligin 1 levels normalizes the increased excitatory synaptic activity and reverses mechanical hypersensitivity. Thus, translational control by 4E-BP1 downstream of mTOR effects the expression of neuroligin 1 and excitatory synaptic transmission in the spinal cord, and thereby contributes to enhanced mechanical nociception. DOI: http://dx.doi.org/10.7554/eLife.12002.001 |
format | Online Article Text |
id | pubmed-4695384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46953842016-03-17 Translational control of nociception via 4E-binding protein 1 Khoutorsky, Arkady Bonin, Robert P Sorge, Robert E Gkogkas, Christos G Pawlowski, Sophie Anne Jafarnejad, Seyed Mehdi Pitcher, Mark H Alain, Tommy Perez-Sanchez, Jimena Salter, Eric W Martin, Loren Ribeiro-da-Silva, Alfredo De Koninck, Yves Cervero, Fernando Mogil, Jeffrey S Sonenberg, Nahum eLife Biochemistry Activation of the mechanistic/mammalian target of rapamycin (mTOR) kinase in models of acute and chronic pain is strongly implicated in mediating enhanced translation and hyperalgesia. However, the molecular mechanisms by which mTOR regulates nociception remain unclear. Here we show that deletion of the eukaryotic initiation factor 4E-binding protein 1 (4E-BP1), a major mTOR downstream effector, which represses eIF4E activity and cap-dependent translation, leads to mechanical, but not thermal pain hypersensitivity. Mice lacking 4E-BP1 exhibit enhanced spinal cord expression of neuroligin 1, a cell-adhesion postsynaptic protein regulating excitatory synapse function, and show increased excitatory synaptic input into spinal neurons, and a lowered threshold for induction of synaptic potentiation. Pharmacological inhibition of eIF4E or genetic reduction of neuroligin 1 levels normalizes the increased excitatory synaptic activity and reverses mechanical hypersensitivity. Thus, translational control by 4E-BP1 downstream of mTOR effects the expression of neuroligin 1 and excitatory synaptic transmission in the spinal cord, and thereby contributes to enhanced mechanical nociception. DOI: http://dx.doi.org/10.7554/eLife.12002.001 eLife Sciences Publications, Ltd 2015-12-18 /pmc/articles/PMC4695384/ /pubmed/26678009 http://dx.doi.org/10.7554/eLife.12002 Text en http://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication (http://creativecommons.org/publicdomain/zero/1.0/) . |
spellingShingle | Biochemistry Khoutorsky, Arkady Bonin, Robert P Sorge, Robert E Gkogkas, Christos G Pawlowski, Sophie Anne Jafarnejad, Seyed Mehdi Pitcher, Mark H Alain, Tommy Perez-Sanchez, Jimena Salter, Eric W Martin, Loren Ribeiro-da-Silva, Alfredo De Koninck, Yves Cervero, Fernando Mogil, Jeffrey S Sonenberg, Nahum Translational control of nociception via 4E-binding protein 1 |
title | Translational control of nociception via 4E-binding protein 1 |
title_full | Translational control of nociception via 4E-binding protein 1 |
title_fullStr | Translational control of nociception via 4E-binding protein 1 |
title_full_unstemmed | Translational control of nociception via 4E-binding protein 1 |
title_short | Translational control of nociception via 4E-binding protein 1 |
title_sort | translational control of nociception via 4e-binding protein 1 |
topic | Biochemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695384/ https://www.ncbi.nlm.nih.gov/pubmed/26678009 http://dx.doi.org/10.7554/eLife.12002 |
work_keys_str_mv | AT khoutorskyarkady translationalcontrolofnociceptionvia4ebindingprotein1 AT boninrobertp translationalcontrolofnociceptionvia4ebindingprotein1 AT sorgeroberte translationalcontrolofnociceptionvia4ebindingprotein1 AT gkogkaschristosg translationalcontrolofnociceptionvia4ebindingprotein1 AT pawlowskisophieanne translationalcontrolofnociceptionvia4ebindingprotein1 AT jafarnejadseyedmehdi translationalcontrolofnociceptionvia4ebindingprotein1 AT pitchermarkh translationalcontrolofnociceptionvia4ebindingprotein1 AT alaintommy translationalcontrolofnociceptionvia4ebindingprotein1 AT perezsanchezjimena translationalcontrolofnociceptionvia4ebindingprotein1 AT salterericw translationalcontrolofnociceptionvia4ebindingprotein1 AT martinloren translationalcontrolofnociceptionvia4ebindingprotein1 AT ribeirodasilvaalfredo translationalcontrolofnociceptionvia4ebindingprotein1 AT dekoninckyves translationalcontrolofnociceptionvia4ebindingprotein1 AT cerverofernando translationalcontrolofnociceptionvia4ebindingprotein1 AT mogiljeffreys translationalcontrolofnociceptionvia4ebindingprotein1 AT sonenbergnahum translationalcontrolofnociceptionvia4ebindingprotein1 |